Impact of 2021 World Health Organization Grading, Peritumoral Edema, and Radiotherapy on the Recurrence of a Grossly Resected Intracranial Meningiomas: A Ten-Year Follow-Up Study

Overview

Journal World J Oncol

Date 2025 Jan 24

PMID 39850529

Authors

Alaa Alkhotani

Saleh Baeesa

Maryam Alshanqiti

Taghreed Alsinani

Ahmed Najjar

Shadi Alkhayyat

Awab Tayyib

Zayed Jastaniah

Abdulrahman J Sabbagh

Nadeem S Butt

Hussain A Alamoudi

Mohammed Alharbi

Basem Bahakeem

Maher Kurdi

Affiliations

Soon will be listed here.

Abstract

Background: The significance of histological grading and peritumoral edema (PTE) in predicting intracranial meningioma recurrence among Saudis is often neglected. This study aimed to evaluate the impact of these factors over a 10-year follow-up period.

Methods: A retrospective cohort of 124 patients with intracranial meningioma was analyzed over the period from 2011 to 2021. All patients underwent gross total resection (GTR) of the tumor. Post-surgical radiotherapy (RT) was offered to patients with grade II-III meningiomas. The impact of histological grading, PTE, and RT on the recurrence-free interval (RFI) was investigated.

Results: The mean age of the patients was 49 years (range: 18 - 84), with 87 females (70.2%) and 37 males (29.8%). Most tumors (88.7%, n = 110) were supratentorial, while 11.3% (n = 14) were infratentorial. The World Health Organization (WHO) grading classified 101 tumors (81.5%) as grade I, 17 (13.7%) as grade II, and six (4.8%) patients as grade III. Grading was significantly associated with RFI (P = 0.013), with grade I meningiomas having the slowest recurrence. The overall recurrence rate was 16.9%, with 38.1% (n = 8) of grade I and 61.9% (n = 13) of grade II-III meningiomas recurring within 5 years post-GTR and RT. There was no significant difference in RFI between RT-exposed and non-exposed patients (P = 0.15). PTE was present in 76 cases (61.3%) and absent in 48 (38.7%), significantly affecting RFI (P = 0.014), with shorter RFI in PTE cases. Overall, 95.2% (n = 118) of patients survived, while 4.8% (n = 6) died; five had grade II-III, and one had grade I meningioma.

Conclusions: Totally, resected intracranial meningiomas with grade II-III features and PTE were associated with earlier tumor recurrence and poorer patient survival. Post-surgical RT had an insignificant effect on the RFI.

References

Goldbrunner R, Stavrinou P, Jenkinson M, Sahm F, Mawrin C, Weber D . EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021; 23(11):1821-1834. PMC: 8563316. DOI: 10.1093/neuonc/noab150. View

Hou J, Kshettry V, Selman W, Bambakidis N . Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy. Neurosurg Focus. 2013; 35(6):E2. DOI: 10.3171/2013.8.FOCUS13301. View

Gilbert J, Paulseth J, Coates R, Malott D . Cerebral edema associated with meningiomas. Neurosurgery. 1983; 12(6):599-605. DOI: 10.1227/00006123-198306000-00001. View

Berhouma M, Jacquesson T, Jouanneau E, Cotton F . Pathogenesis of peri-tumoral edema in intracranial meningiomas. Neurosurg Rev. 2017; 42(1):59-71. DOI: 10.1007/s10143-017-0897-x. View

Ostrom Q, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan J . CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Neuro Oncol. 2020; 22(12 Suppl 2):iv1-iv96. PMC: 7596247. DOI: 10.1093/neuonc/noaa200. View

Behling F, Hempel J, Schittenhelm J . Brain Invasion in Meningioma-A Prognostic Potential Worth Exploring. Cancers (Basel). 2021; 13(13). PMC: 8267840. DOI: 10.3390/cancers13133259. View

Champeaux C, Houston D, Dunn L, Resche-Rigon M . Intracranial WHO grade I meningioma: a competing risk analysis of progression and disease-specific survival. Acta Neurochir (Wien). 2019; . DOI: 10.1007/s00701-019-04096-9. View

Wiemels J, Wrensch M, Claus E . Epidemiology and etiology of meningioma. J Neurooncol. 2010; 99(3):307-14. PMC: 2945461. DOI: 10.1007/s11060-010-0386-3. View

Shin H, Park J, Cho Y, Kim Y, Hong S, Kim J . Risk Factors for High-Grade Meningioma in Brain and Spine: Systematic Review and Meta-analysis. World Neurosurg. 2021; 151:e718-e730. DOI: 10.1016/j.wneu.2021.04.138. View

10.

Balik V, Kourilova P, Sulla I, Vrbkova J, Srovnal J, Hajduch M . Recurrence of surgically treated parasagittal meningiomas: a meta-analysis of risk factors. Acta Neurochir (Wien). 2020; 162(9):2165-2176. DOI: 10.1007/s00701-020-04336-3. View

11.

Sun C, Dou Z, Wu J, Jiang B, Iranmanesh Y, Yu X . The Preferred Locations of Meningioma According to Different Biological Characteristics Based on Voxel-Wise Analysis. Front Oncol. 2020; 10:1412. PMC: 7472960. DOI: 10.3389/fonc.2020.01412. View

12.

Ajlan A, Almeshari S, Basindwah S, Aljohani M, Alharbi Y, Aldhowaihy F . Atypical meningiomas compared to other WHO Grade 2 meningiomas: Histological features and prognosis. Neurosciences (Riyadh). 2024; 29(2):96-102. PMC: 11305365. DOI: 10.17712/nsj.2024.2.20230091. View

13.

Nassehi D . Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Dan Med J. 2013; 60(4):B4626. View

14.

Rezaee H, Abbasnia S, Alenabi A, Vakili R, Moheghi N, Tavakol Afshari J . Expression of Vascular Endothelial Growth Factor A and Its Type 1 Receptor in Supratentorial Neoplasm. Rep Biochem Mol Biol. 2022; 10(3):354-361. PMC: 8718773. DOI: 10.52547/rbmb.10.3.354. View

15.

Sanikommu S, Panchawagh S, Eatz T, Lu V, Bartkevitch Rodrigues P, Abdelsalam A . Recurrence of atypical and anaplastic intracranial Meningiomas: A meta-analysis of risk factors. Clin Neurol Neurosurg. 2024; 244:108450. DOI: 10.1016/j.clineuro.2024.108450. View

16.

Mohammed A, Hamdan A, Homoud A . Histopathological Profile of Brain Tumors: A 12-year Retrospective Study from Madinah, Saudi Arabia. Asian J Neurosurg. 2020; 14(4):1106-1111. PMC: 6896618. DOI: 10.4103/ajns.AJNS_185_19. View

17.

Ahmeti H, Caliebe A, Rocken C, Jansen O, Mehdorn M, Synowitz M . Impact of peritumoral brain edema on pre- and postoperative clinical conditions and on long-term outcomes in patients with intracranial meningiomas. Eur J Med Res. 2023; 28(1):40. PMC: 9862965. DOI: 10.1186/s40001-022-00962-y. View

18.

Zhang R, Chen X, Cai J, Jiang P, Chen Y, Sun B . A Novel MRI-Based Risk Stratification Algorithm for Predicting Postoperative Recurrence of Meningioma: More Benefits to Patients. Front Oncol. 2021; 11:737520. PMC: 8560899. DOI: 10.3389/fonc.2021.737520. View

19.

Maiuri F, Corvino S, Corazzelli G, Berardinelli J, Di Crescenzo R, Del Basso De Caro M . Time to Recurrence of Intracranial Meningiomas from a Monoinstitutional Surgical Series. World Neurosurg. 2024; 185:e612-e619. DOI: 10.1016/j.wneu.2024.02.087. View

20.

Kim D, Niemierko A, Hwang W, Stemmer-Rachamimov A, Curry W, Barker F . Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. J Neurosurg. 2017; 128(4):1123-1132. DOI: 10.3171/2016.11.JNS16913. View